"Receptor Radionuclide Therapy With 177Lu-DOTATOC

Abroad (travel likely)RecruitingPHASE2

Conditions

Neuroendocrine Tumors · Paraganglioma · Pheochromocytoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

AUSL Romagna - Ospedale "M. Bufalini", Cesena, Forlì-Cesena, Italy
Contact: Study coordinator (Federica Matteucci) · federica.matteucci@irst.emr.it · 0543739339
IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l., Meldola, Forlì-Cesena, Italy
Contact: Study coordinator (Maddalena Sansovini) · maddalena.sansovini@ist.emr.it · 0543739100

Study leads

Maddalena Sansovini
Study Chair
IRCCS IRST
Federica Matteucci
Principal Investigator
IRCCS IRST

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor

Neuroendocrine Tumor · Neuroblastoma · Pheochromocytoma

Abroad (travel likely)RecruitingEARLY_PHASE1

Beijing, China

Institutional Registry of Rare Diseases

Rare Diseases · Amyloidosis · Sarcoidosis

Abroad (travel likely)Recruiting

Buenos Aires, Argentina

Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Hepatocellular Carcinoma · Gastrointestinal Cancer Metastatic · Neuroendocrine Tumors

Abroad (travel likely)RecruitingPHASE1, PHASE2

Palo Alto, United States · Philadelphia, United States

Lenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine Tumors

Neuroendocrine Tumors · Well-Differentiated Neuroendocrine Carcinoma · High Grade Neuroendocrine Carcinoma, Any Site

Abroad (travel likely)RecruitingPHASE2

San Francisco, United States